SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

The community is currently locked in a heated debate as the asset struggles to maintain the psychological support level of one dollar, with many investors citing regulatory uncertainty and delays around the Clarity Act as primary drivers for the recent downward pressure. While bearish voices predict further capitulation, a vocal contingent of long-term holders remains bullish, viewing the current price action as an accumulation opportunity and maintaining conviction in the project's long-term utility.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is surging as investors closely monitor the company's strategic pivot toward AI data center infrastructure and potential large-scale leasing deals. Community discourse is heavily focused on the company's power capacity at its Texas facilities, with speculation regarding upcoming tenant agreements driving significant volatility and intense debate over potential share dilution.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors focus on the company's strategic pivot toward AI infrastructure following its acquisition of Northern Data, a move that has significantly expanded its GPU capacity and data center footprint. The community is actively debating the potential for a massive short squeeze due to high short interest, while simultaneously analyzing upcoming earnings and formal guidance as key catalysts for a long-term re-rating.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the B&W segment. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending as investors react to a $200 million stock offering priced at $18.50, with many viewing the institutional participation and use of proceeds for AI-related energy infrastructure as a bullish signal for long-term growth. Community discussion remains focused on the company's massive order backlog and potential for a short squeeze, despite ongoing volatility and debate over the immediate impact of the dilution.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors scrutinize the company's recent trial readouts and anticipation builds for an upcoming BLA submission in late September. Community sentiment is deeply polarized, with bulls pointing to the company's strong cash position and best-in-class pipeline potential, while bears highlight concerns over clinical data efficacy and potential dilution from recent equity incentive plan filings.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle stock is experiencing significant volatility driven by a combination of a post-earnings guidance hike, recent salmonella-related supply chain concerns, and active debate among retail traders regarding potential accumulation versus further downside. While some investors view the recent dip as a buying opportunity, others remain skeptical, citing long-term technical resistance and ongoing concerns over food safety and portion sizes.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending following the announcement of positive Phase 3 trial results for its depression treatment, triggering a significant stock surge as investors weigh the clinical success against potential upcoming share dilution. The community is actively debating the stock's valuation, questioning whether to capitalize on the rally or hold for anticipated Phase 3 data readouts for other indications later this year.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently trending as investors weigh record revenue growth and a ballooning backlog against concerns over narrowing launch windows for the Neutron rocket. The community is sharply divided, with bulls pointing to the company's long-term strategic expansion and massive order book, while bears highlight persistent cash burn and volatility following recent earnings.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holding is experiencing significant market interest driven by its strong revenue growth, successful direct-to-consumer expansion, and aggressive international scaling in the APAC region. While some community members debate the impact of potential tariff headwinds and leadership changes, active discussions highlight the brand's premium market positioning as a primary catalyst for long-term optimism.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea Ltd is currently trending as investors debate its valuation following a significant earnings beat and revenue growth, leading to active community discussions about its long-term potential as a diversified digital ecosystem. Traders are closely monitoring technical support levels and recent institutional activity, weighing the company's strong operational momentum against broader market volatility and insider selling patterns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Century Therapeutics (IPSC) to Present CNTY-813 Data at Scientific Congresses

Century Therapeutics (IPSC) to Present CNTY-813 Data at Scientific Congresses...

A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company

A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company A Third Cancer Drug Just Entered the Clinic at an Under-$20-Million Company PR Newswire SAN FRANCISCO, June 2, 2026 Equity Insider News CommentaryIssued on behalf of GT Biopharma, Inc. (NASDAQ: GTBP)SAN FRANCISCO, June 2...

Wall Street Zen Upgrades Century Therapeutics (NASDAQ:IPSC) to Hold

Wall Street Zen raised Century Therapeutics from a "sell" rating to a "hold" rating in a research note on Sunday...

Century Therapeutics (NASDAQ:IPSC) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen downgraded shares of Century Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...

What is HC Wainwright's Estimate for IPSC Q1 Earnings?

Century Therapeutics, Inc. (NASDAQ:IPSC - Free Report) - Equities researchers at HC Wainwright issued their Q1 2026 EPS estimates for shares of Century Therapeutics in a research note issued on...

Century Therapeutics, Inc. (NASDAQ:IPSC) Given Consensus Recommendation of "Hold" by Brokerages

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) has been given an average recommendation of "Hold" by the seven ratings firms that are presently covering the stock, Marketbeat.com reports...

Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Up 19.3% in March

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 10,289,543 shares, an increase of 19.3% from the March 15th total of 8,626,834 shares. Based on an average daily volume...

Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Update

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 13th, there was short interest totaling 8,626,834...

Century Therapeutics, Inc. (NASDAQ:IPSC) Given Average Recommendation of "Moderate Buy" by Brokerages

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight brokerages that are currently covering the firm, Marketbeat...

Century Therapeutics (NASDAQ:IPSC) Insider Sells $25,693.80 in Stock

Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) insider Gregory Russotti sold 10,076 shares of the business's stock in a transaction that occurred on Thursday, March 12th. The stock was...

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.

Century Therapeutics Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.96
Prev Close	$1.98
Open	$2.02
Dividend Yield	0.00%
50-Day Moving Average	$2.21
Beta	1.64
Avg. Volume	1M
PE Ratio	-1.79

52-Week High	$3.04
52-Week Low	$0.435
Market Capitalization	$357.1M
EPS (Annual)	-$0.1107
Price to Book	1.35
Revenue Per Employee	$1.4M

Feed

News

Sentiment

Earnings

Fundamentals

Info